STRIVE - Trademark Details
Status: 661 - Response After Non-Final Action - Entered
Serial Number
98975541
Word Mark
STRIVE
Status
661 - Response After Non-Final Action - Entered
Status Date
2024-09-05
Filing Date
2023-07-18
Mark Drawing
4 - Standard character mark
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
GERMICK JR., EDWARD
Statements
Goods and Services
Medical devices and apparatus in the field of diabetes, namely, medical devices and apparatus for measuring blood glucose levels and injecting insulin; Medical devices for monitoring blood glucose levels and administering insulin therapy; Medical devices, namely, diabetes management devices, infusion pumps, infusion pump controllers and parts and attachments thereof; Medical devices for insulin therapy, namely, patch pumps for administering continuous subcutaneous insulin infusion; Medical devices, namely, wearable subcutaneous drug delivery devices, sold empty, in the nature of on-body injectors, insulin injectors, infusion pumps, insulin pumps, patch pumps, and controllers, component parts, and attachments therefor; Medical venous access ports, lancets, needles for medical use, syringes for medical use; Pen needles used to deliver medications to manage diabetes; Infusion sets; Infusion pump accessories, namely, belt clips specifically designed for holding infusion pumps and infusion sets; Subcutaneous infusion sets for use by diabetes patients in connection with insulin pumps; Infusion pumps; Insulin pumps; Infusion and insulin pump accessories, namely, medical sensors, meters, and medical devices for measuring and monitoring blood and urine properties; Medical devices and medical apparatus for measuring and monitoring blood and urine properties; Glucose meters; Blood glucose meters; Medical apparatus for monitoring blood glucose levels; Medical apparatus and instruments for monitoring glucose; Continuous glucose monitoring systems comprised of a medical apparatus for monitoring glucose; Sensor-based glucose monitors for medical purposes; Blood glucose monitoring systems including blood glucose monitors, and parts and accessories therefor, namely, blood glucose monitoring carrying cases, and electronic blood glucose test diaries in the nature of integrated computer memory devices within blood glucose monitors; Devices for monitoring blood glucose for medical purposes; Devices for measuring blood sugar; Medical devices, namely, medical sensors that are implanted and inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, data receivers, sensor housings and sensor insertion devices; Medical diagnostic apparatus for testing blood sugar levels incorporating recorded software for the collection, editing, organizing, modifying, transmission, storage and sharing of medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling and managing patient medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for acquiring, analyzing, transmitting and storing medical and physiological data; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for linking medical instruments and devices for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for monitoring blood glucose in connection with blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling insulin delivery in connection with insulin pumps; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for obtaining, controlling, and managing patient medical information on wearable medical devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling and managing wearable insulin delivery devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware used to display, manage, and monitor diabetes management information
Classification Information
International Class
010 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials. - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth; orthopedic articles; suture materials.
US Class Codes
026, 039, 044
Class Status Code
6 - Active
Class Status Date
2023-08-16
Primary Code
010
Current Trademark Owners
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Stephen R. Baird GREENBERG TRAURIG, LLP
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2023-07-21 | NEW APPLICATION ENTERED |
2023-08-16 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
2024-03-01 | ASSIGNED TO EXAMINER |
2024-03-05 | NON-FINAL ACTION WRITTEN |
2024-03-05 | NON-FINAL ACTION E-MAILED |
2024-03-05 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2024-05-16 | TEAS REQUEST TO DIVIDE RECEIVED |
2024-06-04 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
2024-06-04 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
2024-09-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2024-09-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2024-09-05 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2025-02-12 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2024-05-16 | DIVISIONAL REQUEST RECEIVED |
2025-02-12 | DIVISIONAL PROCESSING COMPLETE |